Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 12.


Thwaites, Guy E, Scarborough, Matthew, Szubert, Alexander, Nsutebu, Emmanuel, Tilley, Robert, Greig, Julia, Wyllie, Sarah A, Wilson, Peter, Auckland, Cressida, Cairns, Janet
et al (show 27 more authors) (2018) Adjunctive rifampicin for <i>Staphylococcus aureus</i> bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. LANCET, 391 (10121). pp. 668-678.


Baskaran, Vadsala, Lawrence, Hannah, Lansbury, Louise E, Webb, Karmel, Safavi, Shahideh, Zainuddin, Nurul I, Huq, Tausif, Eggleston, Charlotte, Ellis, Jayne, Thakker, Clare
et al (show 21 more authors) (2021) Co-infection in critically ill patients with COVID-19: an observational cohort study from England. Journal of Medical Microbiology, 70 (4).


Llewelyn, Martin J, Grozeva, Detelina, Howard, Philip, Euden, Joanne, Gerver, Sarah M, Hope, Russell, Heginbothom, Margaret, Powell, Neil, Richman, Colin, Shaw, Dominick
et al (show 5 more authors) (2022) Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (4). pp. 1189-1196.


Llewelyn, Martin J, West, Robert M, Carrol, Enitan D ORCID: 0000-0001-8357-7726, Pallmann, Philip and Sandoe, Jonathan AT
(2022) Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data-authors' response. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (11). pp. 3211-3212.


Liu, Xinxue, Wright, Annie, Feng, Shuo, Janani, Leila, Aley, Parvinder K, Babbage, Gavin, Baker, Jonathan, Baxter, David, Bawa, Tanveer, Bula, Marcin
et al (show 50 more authors) (2023) Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial. JOURNAL OF INFECTION, 87 (1). pp. 18-26.


Liu, Xinxue, Munro, Alasdair PS, Feng, Shuo, Janani, Leila, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna
et al (show 48 more authors) (2022) Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. JOURNAL OF INFECTION, 84 (6). pp. 795-813.


Liu, Xinxue, Munro, Alasdair PS, Feng, Shuo, Janani, Leila, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna
et al (show 48 more authors) (2023) Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial (vol 84, pg 795, 2022). JOURNAL OF INFECTION, 86 (5). pp. 540-541.


Euden, Joanne, Pallmann, Philip, Grozeva, Detelina, Albur, Mahableshwar, Bond, Stuart E, Brookes-Howell, Lucy, Dark, Paul, Hellyer, Thomas, Hopkins, Susan, Howard, Philip
et al (show 16 more authors) (2022) Procalcitonin Evaluation of Antibiotic Use in COVID-19 Hospitalised Patients (PEACH): Protocol for a Retrospective Observational Study. METHODS AND PROTOCOLS, 5 (6). 95-.


Munro, Alasdair PS, Janani, Leila, Cornelius, Victoria, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna, Dodd, Kate
et al (show 44 more authors) (2021) Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. LANCET, 398 (10318). pp. 2258-2276.


Munro, Alasdair PS, Feng, Shuo, Janani, Leila, Cornelius, Victoria, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna
et al (show 45 more authors) (2022) Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. LANCET INFECTIOUS DISEASES, 22 (8). pp. 1131-1141.


Powell, Neil, Howard, Philip, Llewelyn, Martin J, Szakmany, Tamas, Albur, Mahableswhar, Bond, Stuart E, Euden, Joanne, Brookes-Howell, Lucy, Dark, Paul, Hellyer, Thomas P
et al (show 13 more authors) (2021) Use of Procalcitonin during the First Wave of COVID-19 in the Acute NHS Hospitals: A Retrospective Observational Study. ANTIBIOTICS-BASEL, 10 (5). 516-.


Kanagaratnam, Prapa, Francis, Darrel P, Chamie, Daniel, Coyle, Clare, Marynina, Alena, Katritsis, George, Paiva, Patricia, Szigeti, Matyas, Cole, Graham, Nunes, David de Andrade
et al (show 30 more authors) (2023) A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trial. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 21 (8). pp. 2213-2222.

This list was generated on Sun Feb 25 07:24:22 2024 GMT.